Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in CAR-Based Solid Tumor Immunotherapy
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
Alexandra Dreyzin, Alexander W. Rankin, Katia Luciani, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 745-763
Closed Access | Times Cited: 6
PTP1B phosphatase dampens iPSC-derived neutrophil motility and antimicrobial function
Morgan A. Giese, David A. Bennin, Taylor J. Schoen, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 1, pp. 118-131
Closed Access | Times Cited: 5
Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1-magnetic resonance imaging
Yike Hou, Fei Kong, Zhe Tang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 547-563
Closed Access | Times Cited: 5
CAR-macrophage: Breaking new ground in cellular immunotherapy
Ting Huang, Chenqi Bei, Zhenhua Hu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
CAR-T Cell Therapy for Solid Tumors
Liz T. Tony, Andrea Stabile, Marc Philipp Schauer, et al.
Transfusion Medicine and Hemotherapy (2025), pp. 1-13
Open Access
Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots
Zhen Yuan, Jing-Hang Wang, Hao Cui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment
Na Tang, Lei Cheng, Jun Hao, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Therapeutic effects of NK cell-derived EVs on cancer: Current advances and future treatment strategies
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy
Massimo Claudio Fantini, Philip M. Arlen, Kwong Y. Tsang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy
Y Zeng, Qing Gu, Dan Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 12, pp. 2455-2473
Closed Access | Times Cited: 4
Antineoplastic effects of icaritin: molecular mechanisms and applications
Piao Luo, Liyang Zhang, Guangqing Cheng, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access
Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects: A comprehensive review
Kartik Tulsian, Dhruma Thakker, Vivek K. Vyas
International Journal of Biological Macromolecules (2025), pp. 141364-141364
Closed Access
A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
Elitsa Boneva, Velizar Shivarov, Milena Ivanova
Immuno (2025) Vol. 5, Iss. 1, pp. 9-9
Open Access
Mechanistic Study of Cancer Drug Delivery: Current Techniques, Limitations, and Future Prospects
Saiqa Imtiaz, Umme Tamanna Ferdous, Alexis Nizela, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117535-117535
Open Access
Breakthroughs in Cancer Immunotherapy: An Overview of T Cell, NK Cell, Mφ, and DC-Based Treatments
Sun‐Young Lee, Tae‐Don Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17634-17634
Open Access | Times Cited: 10
State of the art and perspectives of CAR-T cell therapy for neuroblastoma
Dzmitry Lutskovich, Alexander Meleshko, Mikalai Katsin
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1122-1131
Closed Access | Times Cited: 3
Immunotherapy in the Treatment of Cancer: Today and Tomorrow
Gökçen Ömeroğlu Şi̇mşek
Current Molecular Biology Reports (2024)
Closed Access | Times Cited: 3
CAR-NK cell therapy in AML: Current treatment, challenges, and advantage
Mohammadmahdi Bahramloo, Sina Alinejad Shahabi, Hossein Kalarestaghi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117024-117024
Open Access | Times Cited: 3
A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?
Alain E. Andrea, Andrada Chiron, Guillaume Sarrabayrouse, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H2Mab‐77‐mG2a‐f
Tomohiro Tanaka, Hiroyuki Suzuki, Tomokazu Ohishi, et al.
Cancer Science (2023) Vol. 115, Iss. 1, pp. 298-309
Open Access | Times Cited: 7
Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies
Laura H. Porter, Sophie Harrison, Gail P. Risbridger, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 243, pp. 106571-106571
Open Access | Times Cited: 2
RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy
Jingsheng Cai, Shaoyi Chen, Zheng Liu, et al.
Immunology (2024) Vol. 173, Iss. 4, pp. 634-653
Closed Access | Times Cited: 2
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top